growth/size/body
• mice start to gain weight around 1 month of age and become obese by 2-3 months of age, independent of diet
• ovariectomy in females blocks obesity development
|
• tumor-bearing males develop splenomegaly
|
hematopoietic system
• increase in lymphocyte population in tumors
|
• spleen of tumor-bearing males contains larger follicles, expanded cortical area, and increase in population of Reed-Steinberg cells (lacunar histiocytes)
|
• tumor-bearing males develop splenomegaly
|
homeostasis/metabolism
• serum ghrelin level is decreased in both fasted and fed males
|
• serum ghrelin level is increased in fasted females
|
• serum IGF-1 levels are increased in tumor-bearing mice
|
• leptin levels are higher in males than females
|
• serum cytokine levels (IL-2, IL-6, IL-10, IL-12, IL-15, IL-18, INF-gamma and TNF-alpha) are decreased in tumor bearing males and to a lesser extent in non-tumor bearing males compared to wild-type males
• serum cytokine levels of IL-10, IL-12, IL-15, IL-18, IFN-gamma, and TNF-alpha in females are higher than in wild-type females
|
• serum chemokine levels of stromal cell-derived factor 1 and granulocyte chemotactic protein 2 are decreased in females but increased in males (of both non-tumor and tumor-bearing males)
• serum C-C chemokine ligand 21 level is increased in males and further increased in tumor-bearing males
|
• ovariectomy in females results in impaired glucose homeostasis
|
• serum insulin levels are higher in both fasted and fed males
|
• males exhibit impaired glucose tolerance at 6 months of age
|
• males, but not females, exhibit impaired insulin tolerance at 6 months of age
• ovariectomy in females results in reduced insulin sensitivity
|
• adiponectin levels are increased in females
|
immune system
• increase in lymphocyte population in tumors
|
• spleen of tumor-bearing males contains larger follicles, expanded cortical area, and increase in population of Reed-Steinberg cells (lacunar histiocytes)
|
• tumor-bearing males develop splenomegaly
|
• serum cytokine levels (IL-2, IL-6, IL-10, IL-12, IL-15, IL-18, INF-gamma and TNF-alpha) are decreased in tumor bearing males and to a lesser extent in non-tumor bearing males compared to wild-type males
• serum cytokine levels of IL-10, IL-12, IL-15, IL-18, IFN-gamma, and TNF-alpha in females are higher than in wild-type females
|
• serum chemokine levels of stromal cell-derived factor 1 and granulocyte chemotactic protein 2 are decreased in females but increased in males (of both non-tumor and tumor-bearing males)
• serum C-C chemokine ligand 21 level is increased in males and further increased in tumor-bearing males
|
• males develop sinus histiocytosis with lymphadenopathy
• tumor-bearing mice develop heterogenous histiocytosis containing histiocytic and dendritic cells
• histiocytosis develops only in hyperinsulinemic males
|
• lymphadenopathy in males that develop sinus histiocytosis
|
neoplasm
• males start to develop multiple tumors around 9 months of age with a prevalence of about 50%
• tumors develop unilaterally or bilaterally in the axillary and/or inguinal lymph nodes near the fore limbs and hind limbs, respectively
• tumors are characteristic of sinus histiocytosis with lymphadenopathy and show gradual expansion of eosinophilic histiocytes within lymph nodes during tumor growth
• females do not develop tumors, however ovariectomy in females results in the development of tumors in 50% of mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
obesity | DOID:9970 |
OMIM:601665 |
J:227976 |